Skip to main content
Log in

Protective effects of prostaglandin I2 analogues on CPK release in rat’s heart-lung preparation

  • Original Articles
  • Published:
Journal of Anesthesia Aims and scope Submit manuscript

Abstract

The effects of prostaglandin I2 analogues (PGI2-a: op-41483 and op-2507) on oxygen toxicity during hyperoxic perfusion were evaluated in an experiment on isolated rat heart lung preparation, with the release of creatine phosphokinase (CPK) in the perfusate blood. There were no significant differences in heart rate and right atrial pressure between PGI2-a treated and untreated hearts. The CPK release from the heart with oxygen was significantly higher than that of the air (P<0.001). However, the CPK release from the PGI2-a treated hearts was significantly less than that from the untreated hearts (P<0.05). These results indicate that PGI2-a may prevent cell damage which was induced by hyperoxia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Lefer AM, Sollott SL, Galvin MJ: Beneficial actions of prostacyclin in traumatic shock. Prostaglandins 17:761–767, 1979

    Article  CAS  PubMed  Google Scholar 

  2. Hallenbeck JM, Furlow TW: Prostaglandin I2 and indomethacin prevent impairment of post-ischemic brain reperfusion in the dog. Stroke 10:629–637, 1979

    CAS  PubMed  Google Scholar 

  3. Masuda Y.|Ochi Y, Karasawa T, Hatano N, Kadokawa T, Okegawa T: Protective effect of a new prostacyclin analogue op-2507 against cerebral anoxia and edema in experimental animals. Eur J Pharmacol 123:335–344, 1986

    Article  CAS  PubMed  Google Scholar 

  4. Terawaki T, Takakuwa T, Iguchi S, Wakitani K, Kira H, Okegawa T.|Kawasaki A, Masuda Y: Effect of a prostacyclin analog op-2507 on acute ischemic cerebral edema in cats. Eur J Pharmacol 152:63–70, 1988

    Article  CAS  PubMed  Google Scholar 

  5. Ogletree ML, Smith JB, Nicolaou KC, Lefer AM: Beneficial actions of prostacyclin (PGI2 ) in myocardial ischemia. Fed Proc 37:566, 1978

    Google Scholar 

  6. Lefer AM, Ogletree ML, Smith JB, Silver MJ, Nicolaou KC, Barnette WE, Gasic GP: Prostacyclin: A potentially valuable agent for preserving myocardial tissue in acute myocardial ischemia. Science 200:52–54. 1978

    Article  CAS  PubMed  Google Scholar 

  7. Ribeiro LG, Brandon TA, Hopkins DG, Reduto LA, Taylor AA, Miller RR: Prostacyclin in experimental myocardial ischemia: Effects on hemodynamics, regional myocardial blood flow, infarct size and mortality. Am J Cardiol 47:835–840, 1981

    Article  CAS  PubMed  Google Scholar 

  8. Schrör K, Darius H, Addicks K, Koster R, Smith EF III: PGI2 prevents ischemia induced alterations in cardiac catecholamines without influencing nervestimulation-induced cathecholamine release in nonischemic conditions. J Cardiovasc Pharmacol 4:741–748, 1982

    Article  PubMed  Google Scholar 

  9. Moncada S, Gryglewski R, Bunting S, Vane JR: An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature 263:663–665, 1976

    Article  CAS  PubMed  Google Scholar 

  10. Aiken JW, Gorman RR, Shebuski RJ: Prevention of blockage of partially obstructed coronary arteries with prostacyclin correlates with inhibition of platelet aggregation. Prostaglandins 17:483–494, 1979

    Article  CAS  PubMed  Google Scholar 

  11. Fujitani B, Wakitani K: Studies on antiplatelet effect of op-41483, a prostaglandin I2 analog, in experimental animals: I. Effect on platelet function and thrombosis. Jap J Pharmacol 52:123–130, 1990

    Article  CAS  PubMed  Google Scholar 

  12. Fujitani B, Wakitani K: Studies on antiplatelet effect of op-41483, a prostaglandin I2 analog, in experimental animals: II. Mechanism of the its antiplatelet effect. Jap J Pharmacol 53:25–33, 1990

    Article  CAS  PubMed  Google Scholar 

  13. Dusting GJ, Moncada S, Vane JR: Prostacyclin (PGX) is the endogenous metabolite responsible for relaxation of coronary arteries induced by arachidonic acid. Prostaglandins 13:3–15, 1977

    Article  CAS  PubMed  Google Scholar 

  14. Ogletree ML, Smith JB, Lefer AM: Actions of prostaglandins on isolated perfused cat coronary arteries. Am J Physiol 235:H400-H406, 1978

    CAS  PubMed  Google Scholar 

  15. Araki H, Lefer AM: Role of prostacyclin in the preservation of ischemic myocardial tissue in the perfused cat heart. Circ Res 47:757–763, 1980

    CAS  PubMed  Google Scholar 

  16. Kashimoto S, Kumazawa T: Protective effects of superoxide dismutase against oxygen toxicity in rat’s heart lung preparation. Jap Circ J 51:1022–1026, 1987

    CAS  PubMed  Google Scholar 

  17. Schrör K, Ohlendorf R, Darius H: Beneficial effects of a new carbacyelin derivative, ZK 36 374, in acute myocardial ischemia. J Pharmacol Exp Ther 219:243–249, 1981

    PubMed  Google Scholar 

  18. Frank L, Bucher JR, Roberts RJ: Oxygen toxicity in neonatal and adult animals of various species. J Appl Physiol: Respirat Environ Exercise Physiol 45:699–704, 1978

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

About this article

Cite this article

Kashimoto, S., Nakamura, T., Oguchi, T. et al. Protective effects of prostaglandin I2 analogues on CPK release in rat’s heart-lung preparation. J Anesth 5, 359–362 (1991). https://doi.org/10.1007/s0054010050359

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s0054010050359

Key words

Navigation